Synergy Pharmaceuticals buy tamam
Start price
18.03.17
/
50%
€4.56
Target price
22.05.17
€11.28
Performance (%)
-21.74%
End price
22.05.17
€3.57
Summary
This prediction ended on 22.05.17 with a price of €3.57. The prediction for Synergy Pharmaceuticals disappointed with a performance of -21.74%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Synergy Pharmaceuticals | - | - | - | - |
| iShares Core DAX® | 0.336% | 4.366% | 21.868% | 63.911% |
| iShares Nasdaq 100 | 0.541% | 3.170% | 7.017% | 108.934% |
| iShares Nikkei 225® | 4.048% | 6.727% | 22.855% | 57.329% |
| iShares S&P 500 | 0.795% | 3.281% | 4.698% | 67.940% |
Comments by tamam for this prediction
In the thread Synergy Pharmaceuticals diskutieren
tamam stimmt der Analystenmeinung von 'Buy' zu
Potential Catalysts: SNDA submission for Trulance for IBS-C.
Initial sales of Trulance.
Buyout Offer.
(Vom Mitglied beendet)
Stopped prediction by tamam for Synergy Pharmaceuticals
Synergy Pharmaceuticals
Start price
Target price
Perf. (%)
€2.34
25.09.17
25.09.17
€6.31
13.12.18
13.12.18
-94.98%
13.12.18
13.12.18
Synergy Pharmaceuticals
Start price
Target price
Perf. (%)
€5.93
06.10.15
06.10.15
€10.82
06.04.16
06.04.16
-57.53%
06.04.16
06.04.16